Jihua M. Guo

237 Luoyu Road
Wuhan, 430079, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

SRSF3 determines Treg cell fate in antitumor immunity and autoimmunity.

SRSF3 determines Treg cell fate in antitumor immunity and autoimmunity.

Journal: Science advances

Published: May 29, 2026

Emerging roles of m6A modification in endodontic diseases: a systematic review.

Emerging roles of m6A modification in endodontic diseases: a systematic review.

Journal: Epigenomics

Published: May 04, 2026

Alternative splicing of immune checkpoints: Classifications, mechanisms, and therapeutic implications for overcoming immune checkpoint blockade resistance.

Alternative splicing of immune checkpoints: Classifications, mechanisms, and therapeutic implications for overcoming immune checkpoint blockade resistance.

Journal: Critical reviews in oncology/hematology

Published: March 01, 2026

The RNA methyltransferase NSUN2 catalyzes 5-methylcytosine (m5C) on IL1B mRNA to promote transcript stability.

The RNA methyltransferase NSUN2 catalyzes 5-methylcytosine (m5C) on IL1B mRNA to promote transcript stability.

Journal: The Journal of biological chemistry

Published: September 23, 2025

AARS1 and AARS2: From Protein Synthesis to Lactylation-Driven Oncogenesis.

AARS1 and AARS2: From Protein Synthesis to Lactylation-Driven Oncogenesis.

Journal: Biomolecules

Published: July 29, 2025

RUNX2 isoform II protects cancer cells from ferroptosis and apoptosis by promoting PRDX2 expression in oral squamous cell carcinoma.

RUNX2 isoform II protects cancer cells from ferroptosis and apoptosis by promoting PRDX2 expression in oral squamous cell carcinoma.

Journal: eLife

Published: June 11, 2025

The splicing factor SRSF6 mediates ferroptosis resistance in head and neck squamous cell carcinoma through induction of stearoyl-CoA desaturase.

The splicing factor SRSF6 mediates ferroptosis resistance in head and neck squamous cell carcinoma through induction of stearoyl-CoA desaturase.

Journal: The Journal of biological chemistry

Published: January 21, 2025

N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy.

N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy.

Journal: Biomolecules

Published: September 15, 2024

Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.

Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: October 23, 2023

Salivary Extracellular Vesicles: Biomarkers and Beyond in Human Diseases.

Salivary Extracellular Vesicles: Biomarkers and Beyond in Human Diseases.

Journal: International journal of molecular sciences

Published: October 18, 2023

Treg plasticity and human diseases.

Treg plasticity and human diseases.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: August 07, 2023

An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.

An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.

Journal: International immunopharmacology

Published: August 04, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026